Table of Contents
International Journal of Molecular Imaging
Volume 2012 (2012), Article ID 412585, 7 pages
http://dx.doi.org/10.1155/2012/412585
Clinical Study

Contribution of 18F-Fluoro-ethyl-tyrosine Positron Emission Tomography to Target Volume Delineation in Stereotactic Radiotherapy of Malignant Cranial Base Tumours: First Clinical Experience

1Department of Radiation Oncology, Charité Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany
2Department of Nuclear Medicine, Charité Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany
3Department of Radiation Oncology, Klinikum Frankfurt (Oder), Müllroser Chaussee 7, 15236 Frankfurt, Germany

Received 24 April 2012; Revised 16 September 2012; Accepted 30 September 2012

Academic Editor: Habib Zaidi

Copyright © 2012 Reinhold Graf et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. L. Grosu, W. A. Weber, S. T. Astner et al., “11C-methionine PET improves the target volume delineation of meningiomas treated with stereotactic fractionated radiotherapy,” International Journal of Radiation Oncology Biology Physics, vol. 66, no. 2, pp. 339–344, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. D. D. Durden and D. W. Williams III, “Radiology of skull base neoplasms,” Otolaryngologic Clinics of North America, vol. 34, no. 6, pp. 1043–1064, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. R. T. Ullrich, L. W. Kracht, and A. H. Jacobs, “Neuroimaging in patients with gliomas,” Seminars in Neurology, vol. 28, no. 4, pp. 484–494, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. K. J. Langen, K. Hamacher, M. Weckesser et al., “O-(2-[18F]fluoroethyl)-l-tyrosine: uptake mechanisms and clinical applications,” Nuclear Medicine and Biology, vol. 33, no. 3, pp. 287–294, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Pauleit, A. Zimmermann, G. Stoffels et al., “18F-FET PET compared with 18F-FDG PET and CT in patients with head and neck cancer,” Journal of Nuclear Medicine, vol. 47, no. 2, pp. 256–261, 2006. View at Google Scholar · View at Scopus
  6. A. L. Grosu, S. T. Astner, E. Riedel et al., “An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- andL-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases,” International Journal of Radiation Oncology, Biology, Physics, vol. 81, no. 4, pp. 1049–1058, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Stockhammer, M. Plotkin, H. Amthauer, F. K. van Landeghem, and C. Woiciechowsky, “Correlation of F-18-fluoro-ethyl-tyrosin uptake with vascular and cell density in non-contrast-enhancing gliomas,” Journal of Neuro-Oncology, vol. 88, no. 2, pp. 205–210, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. J. M. Derlon, M. C. Petit-Taboué, F. Chapon et al., “The in vivo metabolic pattern of low-grade brain gliomas: a positron emission tomographic study using 18F-fluorodeoxyglucose and 11C-L-methylmethionine,” Neurosurgery, vol. 40, no. 2, pp. 276–287, 1997. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Okita, M. Kinoshita, T. Goto et al., “11C-methionine uptake correlates with tumor cell density rather than with microvessel density in glioma: a stereotactic image-histology comparison,” NeuroImage, vol. 49, no. 4, pp. 2977–2982, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. R. L. Wahl, J. M. Herman, and E. Ford, “The promise and pitfalls of positron emission tomography and single-photon emission computed tomography molecular imaging-guided radiation therapy,” Seminars in Radiation Oncology, vol. 21, no. 2, pp. 88–100, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Alber, F. Paulsen, S. M. Eschmann, and H. J. Machulla, “On biologically conformal boost dose optimization,” Physics in Medicine and Biology, vol. 48, no. 2, pp. N31–N35, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. M. D. Piroth, M. Pinkawa, R. Holy et al., “Integrated boost IMRT with FET-PET-adapted local dose escalation in glioblastomas: results of a prospective phase II study,” Strahlentherapie und Onkologie, vol. 188, no. 4, pp. 334–339, 2012. View at Google Scholar
  13. F. Nyuyki, M. Plotkin, R. Graf et al., “Potential impact of 68Ga-DOTATOC PET/CT on stereotactic radiotherapy planning of meningiomas,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 37, no. 2, pp. 310–318, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. S. T. Astner, M. Dobrei-Ciuchendea, M. Essler et al., “Effect of 11C-methionine-positron emission tomography on gross tumor volume delineation in stereotactic radiotherapy of skull base meningiomas,” International Journal of Radiation Oncology Biology Physics, vol. 72, no. 4, pp. 1161–1167, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. M. L. Calcagni, G. Galli, A. Giordano et al., “Dynamic O-(2-[18F]fluoroethyl)-L-tyrosine (F-18 FET) PET for glioma grading: assessment of individual probability of malignancy,” Clinical Nuclear Medicine, vol. 36, no. 10, pp. 841–847, 2011. View at Google Scholar
  16. G. Pöpperl, F. W. Kreth, J. H. Mehrkens et al., “FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 34, no. 12, pp. 1933–1942, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. W. A. Weber, H. J. Wester, A. L. Grosu et al., “O-(2-[18F]fluoroethyl)-L-tyrosine and L-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study,” European Journal of Nuclear Medicine, vol. 27, no. 5, pp. 542–549, 2000. View at Google Scholar · View at Scopus
  18. D. Pauleit, G. Stoffels, W. Schaden et al., “PET with O-(2-18F-fluoroethyl)-L-tyrosine in peripheral tumors: first clinical results,” Journal of Nuclear Medicine, vol. 46, no. 3, pp. 411–416, 2005. View at Google Scholar · View at Scopus
  19. S. Balogova, S. Périé, K. Kerrou et al., “Prospective comparison of FDG and FET PET/CT in patients with head and neck squamous cell carcinoma,” Molecular Imaging and Biology, vol. 10, no. 6, pp. 364–373, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. S. K. Haerle, D. R. Fischer, D. T. Schmid, N. Ahmad, G. F. Huber, and A. Buck, “18F-FET PET/CT in advanced head and neck squamous cell carcinoma: an intra-individual comparison with 18F-FDG PET/CT,” Molecular Imaging and Biology, vol. 13, no. 5, pp. 1036–1042, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. S. H. Ng, S. C. Chan, T. C. Yen et al., “Staging of untreated nasopharyngeal carcinoma with PET/CT: comparison with conventional imaging work-up,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 36, no. 1, pp. 12–22, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Bayne, R. J. Hicks, S. Everitt et al., “Reproducibility of “intelligent” contouring of gross tumor volume in non-small-cell lung cancer on PET/CT images using a standardized visual method,” International Journal of Radiation Oncology Biology Physics, vol. 77, no. 4, pp. 1151–1157, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Vees, S. Senthamizhchelvan, R. Miralbell, D. C. Weber, O. Ratib, and H. Zaidi, “Assessment of various strategies for 18F-FET PET-guided delineation of target volumes in high-grade glioma patients,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 36, no. 2, pp. 182–193, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Rickhey, O. Koelbl, C. Eilles, and L. Bogner, “A biologically adapted dose-escalation approach, demonstrated for 18F-FET-PET in brain tumors,” Strahlentherapie und Onkologie, vol. 184, no. 10, pp. 536–542, 2008. View at Publisher · View at Google Scholar · View at Scopus